Adagene(us:ADAG)

    1.83

    -10.73%

    Updated on 2024-12-23

    Open:1.96
    Close:1.83
    High:1.96
    Low:1.74
    Pre Close:2.05
    Volume:56295.00
    Amount:105726.52
    Turnover:0.10%
    Shares:55.34M
    MarketCap:101.27M

    About Adagene Company

    Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

    Company Name: Adagene
    Company Address: Suzhou Industrial Park,No. 218 Xingh Street,4/F, Building C14
    Employees: 174
    Fiscar Year: 12-31
    IPO Date: 2021-02-09
    CIK: 1818838

    View all SEC Filings

    About

    Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
    Address:Suzhou Industrial Park,No. 218 Xingh Street,4/F, Building C14

    Market Movers